Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano Silver Fluoride vs Chlorhexidine in Carious Molars
NCT03186261Phase 3Completed
- Sponsor
- Cairo University
- Start
- Apr 2018
- Primary completion
- Nov 2018
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nanosilver fluoride in dental caries, sponsored by Cairo University. Primary endpoint: Bacterial Count of Streptococcus Mutans at 5 minutes. Started Apr 2018; status: completed.
02
Drugs
nanosilver fluoride
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT03186261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186261.